Cargando…
Leukocytoclastic vasculitis with purpura and renal failure induced by the anti-epidermal growth factor receptor antibody panitumumab: a case report
BACKGROUND: Panitumumab is the first human combinatorial antibody for the treatment of metastatic colorectal carcinoma. Dermatologic toxicity of all grades occurs in more than 90% of patients. However, there are few reports of purpura induced by anti-epidermal growth factor receptor antibody. Renal...
Autores principales: | Kamo, Hitomi, Shinozaki, Eiji, Sugase, Takanobu, Mizunuma, Nobuyuki, Taniguchi, Shoji, Gotoh, Takashi, Chin, Keisyo, Tanaka, Tomoaki, Koga, Kazumi, Yamaguchi, Kensei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334399/ https://www.ncbi.nlm.nih.gov/pubmed/30646927 http://dx.doi.org/10.1186/s13256-018-1877-7 |
Ejemplares similares
-
The Many Faces of Purpura: Vancomycin-Induced Leukocytoclastic Vasculitis
por: Zadroga, John A., et al.
Publicado: (2021) -
Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's Disease
por: Kishimoto, Kenichi, et al.
Publicado: (2020) -
Resection of lesions in the ileum of patients with IgG4-related disease may ameliorate disease progression without steroid administration
por: Watanabe, Akihiro, et al.
Publicado: (2018) -
Tozinameran: Immunoglobulin A-dominant leukocytoclastic vasculitis (Henoch-Schonlein purpura): case report
Publicado: (2022) -
Vancomycin-Associated Leukocytoclastic Vasculitis
por: Pongruangporn, Makhawadee, et al.
Publicado: (2011)